デフォルト表紙
市場調査レポート
商品コード
1529563

禁煙・ニコチン依存症対策製品市場:投与経路別、製品別、流通チャネル別、地域別

Smoking Cessation and Nicotine De-addiction Products Market, By Route of Administration, By Product, By Distribution Channel, By Geography

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 358 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.96円
禁煙・ニコチン依存症対策製品市場:投与経路別、製品別、流通チャネル別、地域別
出版日: 2024年07月18日
発行: Coherent Market Insights
ページ情報: 英文 358 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

禁煙・ニコチン依存症対策製品の世界市場は、2024年には165億5,000万米ドルと推定され、2024~2031年のCAGRは17.1%を示し、2031年には501億米ドルに達すると予測されています。

レポート範囲 レポート詳細
基準年 2023年 2024年の市場規模 165億5,000万米ドル
実績データ 2019~2023年 予測期間 2024~2031年
予測期間2024~2031年のCAGR 17.10% 2031年の金額予測 501億米ドル
図.禁煙・ニコチン依存症対策製品市場シェア(%)(2024年、地域別)
Smoking Cessation and Nicotine De-addiction Products Market-IMG1

禁煙・ニコチン依存症対策製品の世界市場は、世界の喫煙者人口の増加と喫煙による健康被害に対する意識の高まりにより大きく成長しています。喫煙は世界の公衆衛生問題になっており、世界保健機関(WHO)はタバコの摂取をやめるためのさまざまな対策を推奨しています。ニコチン置換療法やその他の禁煙補助剤は、喫煙者の習慣を断ち切るのに有効であることが証明されています。政府やNGOによるいくつかの啓発キャンペーンが、禁煙のためのニコチンガム、パッチ、トローチ、処方薬の需要を押し上げています。製品の処方や新技術の進歩により、禁煙を望む喫煙者の選択肢は広がっています。しかし、特定の禁煙補助製品の高価格とタバコ中毒の根強さが業界の課題となっています。

市場力学:

世界の禁煙・ニコチン依存症対策製品市場の成長は、喫煙関連疾患の有病率の増加、消費者の健康意識の高まり、タバコの使用を抑制するための公的機関による様々な取り組みが牽引しています。しかし、特定の禁煙療法には高額な費用がかかること、製品規制に反対するタバコ業界のロビー活動が強いことが、市場の成長を抑制しています。禁煙治療のためのデジタルソリューションの普及が新たな機会を開いています。さまざまなモバイルアプリやオンラインプログラムが開発され、ニコチン代替療法の効果や消費者の行動サポートを向上させています。ニコチンの代替デリバリー形態の革新も、牽引力を増している主要動向です。

本調査の主要特徴

  • 本レポートでは、世界の禁煙・ニコチン依存症対策製品市場を詳細に分析し、2023年を基準年とした予測期間(2024~2031年)の市場規模(10億米ドル)と複合年間成長率(CAGR%)を掲載しています。
  • また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。
  • また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
  • 世界の禁煙・ニコチン依存症対策製品市場における主要企業プロファイルを、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいて掲載しています。
  • 本レポートから洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
  • 禁煙・ニコチン依存症対策製品の世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
  • 利害関係者は、世界の禁煙・ニコチン依存症対策製品市場分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブ概要
  • 一貫型機会マップ(COM)

第3章 市場力学、規制、動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 影響分析
  • 市場動向
  • 規制シナリオ
  • 買収と提携のシナリオ
  • 資金調達と投資
  • PEST分析
  • ポーターの分析

第4章 世界の禁煙・ニコチン依存症対策製品市場-コロナウイルス(COVID-19)パンデミックの影響

  • 全体的な影響
  • 政府の取り組み
  • COVID-19による市場への影響

第5章 世界の禁煙・ニコチン依存症対策製品市場、投与経路別、2019~2031年(10億米ドル)

  • イントロダクション
  • 経口
  • 経皮
  • 鼻腔
  • 舌下投与

第6章 世界の禁煙・ニコチン依存症対策製品市場、製品別、2019~2031年(10億米ドル)

  • イントロダクション
  • ニコチン置換療法
  • ニコチンスプレー
  • ニコチン吸入器
  • ニコチンガム
  • ニコチン経皮パッチ
  • ニコチン舌下錠
  • ニコチントローチ
  • 薬剤療法
  • バレニクリン
  • ザイバン
  • ニコレットバッカル
  • 電子タバコ/電子リキッド

第7章 世界の禁煙・ニコチン依存症対策製品市場、流通チャネル別、2019~2031年(10億米ドル)

  • イントロダクション
  • 病院薬局
  • オンライン薬局
  • 小売薬局

第8章 世界の禁煙・ニコチン依存症対策製品市場、地域別、2019~2031年(10億米ドル)

  • イントロダクション
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • 中東

第9章 競合情勢

  • 企業プロファイル
    • GlaxoSmithKline plc(GSK)
    • Pfizer Inc.
    • Johnson &Johnson
    • Novartis International AG
    • Imperial Brands plc
    • British American Tobacco plc(BAT)
    • Cipla Inc.
    • McNeil AB
    • NJOY, Inc.
    • Dr. Reddy's Laboratories Ltd.
    • Perrigo Company plc
    • Fertin Pharma
    • Philip Morris International Inc.
    • Alkalon A/S
    • Japan Tobacco Inc.
    • Nicotek, LLC
    • 22nd Century Group Inc.

第10章 アナリストの推奨事項

  • 隆盛と衰退
  • 一貫型機会マップ

第11章 参考文献と調査手法

  • 参考文献
  • 調査手法
目次
Product Code: CMI134

The Global Smoking Cessation and Nicotine De-addiction Products Market is estimated to be valued at USD 16.55 Bn in 2024 and is expected to reach USD 50.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 17.1% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 16.55 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 17.10% 2031 Value Projection: US$ 50.10 Bn
Figure. Smoking Cessation and Nicotine De-addiction Products Market Share (%), By Region 2024
Smoking Cessation and Nicotine De-addiction Products Market - IMG1

The global market for smoking cessation and nicotine de-addiction products is growing significantly owing to the rising global population of smokers and increasing awareness about health hazards of smoking. Smoking has become a worldwide public health issue and the World Health Organization (WHO) recommends various measures to help people quit tobacco consumption. Nicotine replacement therapies and other smoking cessation aids are proving effective in assisting smokers to break the habit. Several awareness campaigns by governments and NGOs have boosted the demand for nicotine gums, patches, lozenges and prescription medications for quitting smoking. Advancements in product formulations and newer technologies are expanding the choices available to smokers who want to quit. However, high prices of certain de-addiction products and persistence of tobacco addiction pose challenges to the industry.

Market Dynamics:

The global smoking cessation and nicotine de-addiction products market growth is driven by the increasing prevalence of smoking-related diseases, growing health consciousness among consumers, and various initiatives by public organizations to curb tobacco use. However, high costs of certain smoking cessation therapies, along with strong tobacco industry lobbying against product regulations, are restraining the market growth. The widespread adoption of digital solutions for smoking cessation therapies is opening new opportunities. Various mobile apps and online programs are being developed to improve the effectiveness of nicotine replacement therapies and behavioral support for consumers. Innovation in alternate delivery forms of nicotine is another key trend gaining traction.

Key Features of the Study:

  • This report provides in-depth analysis of the global smoking cessation and nicotine de-addiction products market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global smoking cessation and nicotine de-addiction products market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include GlaxoSmithKline, Pfizer, Johnson & Johnson, and Dr. Reddy's Laboratories
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global smoking cessation and nicotine de-addiction products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global smoking cessation and nicotine de-addiction products market.

Detailed Segmentation-

  • By Route of Administration
    • Oral
    • Transdermal
    • Nasal
    • Sublingual
    • Oral
  • By Product
    • Nicotine Replacement Therapy
    • Nicotine Spray
    • Nicotine Inhalers
    • Nicotine Gum
    • Nicotine Transdermal Patches
    • Nicotine Sublingual Tablets
    • Nicotine Lozenges
    • Drug Therapy
    • Varenicline
    • Zyban
    • Nicorette Buccal
    • E-cigarettes/E-liquid
  • By Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • GlaxoSmithKline plc (GSK)
    • Pfizer Inc.
    • Johnson & Johnson
    • Novartis International AG
    • Imperial Brands plc
    • British American Tobacco plc (BAT)
    • Cipla Inc.
    • McNeil AB
    • NJOY, Inc.
    • Reddy's Laboratories Ltd.
    • Perrigo Company plc
    • Fertin Pharma
    • Philip Morris International Inc.
    • Alkalon A/S
    • Japan Tobacco Inc.
    • Nicotek, LLC
    • 22nd Century Group Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Product
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Smoking Cessation and Nicotine De-addiction Products Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Smoking Cessation and Nicotine De-addiction Products Market, By Route of Administration, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Oral
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Transdermal
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Nasal
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Sublingual
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Smoking Cessation and Nicotine De-addiction Products Market, By Product, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Nicotine Replacement Therapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Nicotine Spray
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Nicotine Inhalers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Nicotine Gum
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Nicotine Transdermal Patches
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Nicotine Sublingual Tablets
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Nicotine Lozenges
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Drug Therapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Varenicline
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Zyban
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Nicorette Buccal
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • E-cigarettes/E-liquid
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Smoking Cessation and Nicotine De-addiction Products Market, By Distribution Channel, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Hospital Pharmacy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Online Pharmacy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Retail Pharmacy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Smoking Cessation and Nicotine De-addiction Products Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • GlaxoSmithKline plc (GSK)
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Pfizer Inc.
    • Johnson & Johnson
    • Novartis International AG
    • Imperial Brands plc
    • British American Tobacco plc (BAT)
    • Cipla Inc.
    • McNeil AB
    • NJOY, Inc.
    • Dr. Reddy's Laboratories Ltd.
    • Perrigo Company plc
    • Fertin Pharma
    • Philip Morris International Inc.
    • Alkalon A/S
    • Japan Tobacco Inc.
    • Nicotek, LLC
    • 22nd Century Group Inc.

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact